This novel immunodeficiency, similar to activated PI3 kinase delta syndrome (APDS) due to mutations of another subunit of the PI3K pathway, p110δ, is characterized by elevated IgM and low IgG serum levels, recurrent respiratory infections, lymph node enlargement, poor growth, and elevated risk to develop lymphomas. Here, CD40LG is linked to activated PI3K-delta syndrome.